GB0707617D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0707617D0
GB0707617D0 GB0707617A GB0707617A GB0707617D0 GB 0707617 D0 GB0707617 D0 GB 0707617D0 GB 0707617 A GB0707617 A GB 0707617A GB 0707617 A GB0707617 A GB 0707617A GB 0707617 D0 GB0707617 D0 GB 0707617D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0707617A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0707617A priority Critical patent/GB0707617D0/en
Publication of GB0707617D0 publication Critical patent/GB0707617D0/en
Priority to EA200970967A priority patent/EA016443B1/ru
Priority to DE602008005285T priority patent/DE602008005285D1/de
Priority to JP2010503494A priority patent/JP5313229B2/ja
Priority to EP08736315A priority patent/EP2137181B1/en
Priority to US12/596,488 priority patent/US8324254B2/en
Priority to MX2009011155A priority patent/MX2009011155A/es
Priority to KR1020097021613A priority patent/KR20090130062A/ko
Priority to AT08736315T priority patent/ATE500252T1/de
Priority to CA002684385A priority patent/CA2684385A1/en
Priority to JO2008183A priority patent/JO2686B1/en
Priority to NZ579595A priority patent/NZ579595A/en
Priority to CN200880012733.XA priority patent/CN101663297B/zh
Priority to PE2008000672A priority patent/PE20090150A1/es
Priority to MYPI20094368A priority patent/MY146606A/en
Priority to TW097113880A priority patent/TWI408137B/zh
Priority to ARP080101584A priority patent/AR066095A1/es
Priority to CL200801099A priority patent/CL2008001099A1/es
Priority to BRPI0809472-1A priority patent/BRPI0809472A2/pt
Priority to AU2008240773A priority patent/AU2008240773B2/en
Priority to PCT/EP2008/054647 priority patent/WO2008128951A1/en
Priority to ZA200906256A priority patent/ZA200906256B/xx
Priority to IL200870A priority patent/IL200870A/en
Priority to DO2009000237A priority patent/DOP2009000237A/es
Priority to MA32280A priority patent/MA31311B1/fr
Priority to CO09115828A priority patent/CO6321136A2/es
Priority to CR11119A priority patent/CR11119A/es
Priority to HK10104250.5A priority patent/HK1138001A1/xx
Ceased legal-status Critical Current

Links

GB0707617A 2007-04-19 2007-04-19 Compounds Ceased GB0707617D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GB0707617A GB0707617D0 (en) 2007-04-19 2007-04-19 Compounds
PCT/EP2008/054647 WO2008128951A1 (en) 2007-04-19 2008-04-17 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
CN200880012733.XA CN101663297B (zh) 2007-04-19 2008-04-17 用作1-磷酸鞘氨醇（s1p）激动剂的*二唑取代的吲唑衍生物
MYPI20094368A MY146606A (en) 2007-04-19 2008-04-17 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
JP2010503494A JP5313229B2 (ja) 2007-04-19 2008-04-17 スフィンゴシン１−リン酸（ｓ１ｐ）アゴニストとして用いるためのオキサジアゾール置換インダゾール誘導体
EP08736315A EP2137181B1 (en) 2007-04-19 2008-04-17 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
US12/596,488 US8324254B2 (en) 2007-04-19 2008-04-17 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
MX2009011155A MX2009011155A (es) 2007-04-19 2008-04-17 Derivados de indazol oxadiazol sustituidos para su uso como agonistas de esfingosina-1-fosfato (s1p).
KR1020097021613A KR20090130062A (ko) 2007-04-19 2008-04-17 스핑고신 １―포스페이트 (ｓ１ｐ) 효능제로서 사용하기 위한 옥사디아졸 치환된 인다졸 유도체
AT08736315T ATE500252T1 (de) 2007-04-19 2008-04-17 Oxadiazolsubstituierte indazolderivate zur verwendung als sphingosin-1-phosphat (s1p) - agonisten
CA002684385A CA2684385A1 (en) 2007-04-19 2008-04-17 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
JO2008183A JO2686B1 (en) 2007-04-19 2008-04-17 Vehicles
NZ579595A NZ579595A (en) 2007-04-19 2008-04-17 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
EA200970967A EA016443B1 (ru) 2007-04-19 2008-04-17 Оксадиазолзамещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (s1p)
PE2008000672A PE20090150A1 (es) 2007-04-19 2008-04-17 Compuestos derivados de oxadiazol
DE602008005285T DE602008005285D1 (de) 2007-04-19 2008-04-17 Oxadiazolsubstituierte indazolderivate zur verwendung als sphingosin-1-phosphat (s1p) -agonisten
TW097113880A TWI408137B (zh) 2007-04-19 2008-04-17 經取代之二唑衍生物、其醫藥用途及醫藥組合物
ARP080101584A AR066095A1 (es) 2007-04-19 2008-04-17 Compuesto de oxadiazol su uso para preparar un medicamento composicion farmaceutica que lo comprende y procedimiento para prepararla
CL200801099A CL2008001099A1 (es) 2007-04-19 2008-04-17 Compuestos derivados de indazol; y su uso para tratar enfermedades mediadas por los receptores s1p1, tales como esclerosis multiple, enfermedad autoinmune, trastornos inflamatorios, diabetes, entre otras.
BRPI0809472-1A BRPI0809472A2 (pt) 2007-04-19 2008-04-17 Derivados indazol substituídos com oxadiazol para emprego como agonistas de esfingosina 1-fosfato (sip)
AU2008240773A AU2008240773B2 (en) 2007-04-19 2008-04-17 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
ZA200906256A ZA200906256B (en) 2007-04-19 2009-09-09 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
IL200870A IL200870A (en) 2007-04-19 2009-09-10 Indazole history is preserved with oxydiazole, and its use in the preparation of drugs to treat diseases mediated by sphingosine 1-phosphate (p1s)
DO2009000237A DOP2009000237A (es) 2007-04-19 2009-10-08 Derivados de indazol oxadiazol sustituidos para uso como agonistas esfingosina 1-fosfato (s1p)
MA32280A MA31311B1 (fr) 2007-04-19 2009-10-15 Dérivés d'indazole substitués par oxadiazole, destinés à être utilisés comme agonistes de la sphingosine 1-phosphate (s1p)
CO09115828A CO6321136A2 (es) 2007-04-19 2009-10-16 Derivados de indazol sustituido por axadiazol para uso como agonistas de esfingosina 1 fosfato (s1p)
CR11119A CR11119A (es) 2007-04-19 2009-11-19 Derivados de indazol oxadiazol sustituidos para uso como agonistas esfingozina 1-fosfato (sip)
HK10104250.5A HK1138001A1 (en) 2007-04-19 2010-04-29 Oxadiazole substituted indazole derivatives for use as sphingosine 1- phosphate (s1p) agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0707617A GB0707617D0 (en) 2007-04-19 2007-04-19 Compounds

Publications (1)

Publication Number Publication Date
GB0707617D0 true GB0707617D0 (en) 2007-05-30

Family

ID=38135111

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0707617A Ceased GB0707617D0 (en) 2007-04-19 2007-04-19 Compounds

Country Status (3)

Country Link
CN (1) CN101663297B (zh)
GB (1) GB0707617D0 (zh)
ZA (1) ZA200906256B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105474014B (zh) * 2013-08-20 2017-04-05 明治制果药业株式会社 S1p1受体激动剂的评价方法和筛选方法

Also Published As

Publication number Publication date
CN101663297A (zh) 2010-03-03
CN101663297B (zh) 2013-05-08
ZA200906256B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
GB0706793D0 (en) Compounds
GB0704407D0 (en) Compounds
GB0704394D0 (en) Compounds
GB0705672D0 (en) Compounds
GB0706173D0 (en) Compounds
GB0707092D0 (en) Compounds
GB0706188D0 (en) Compounds
GB0706168D0 (en) Compounds
GB0706165D0 (en) Compounds
GB0707034D0 (en) Compounds
GB0706174D0 (en) Compounds
GB0706189D0 (en) Compounds
GB0706187D0 (en) Compounds
GB0706167D0 (en) Compounds
GB0706170D0 (en) Compounds
GB0706190D0 (en) Compounds
GB0706164D0 (en) Compounds
GB0704939D0 (en) Compounds
GB0703756D0 (en) Compounds
GB0701985D0 (en) Compounds
GB0701955D0 (en) Compounds
GB0706023D0 (en) Compounds
GB0702960D0 (en) Compounds
GB0701981D0 (en) Compounds
GB0701977D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)